"Phase III studies are randomized controlled multicenter trials on large patient groups (300–3,000 or more depending upon the disease/medical condition studied) and are aimed at being the definitive assessment of how effective the drug is, in comparison with current 'gold standard' treatment. Because of their size and comparatively long duration, Phase III trials are the most expensive, time-consuming and difficult trials to design and run, especially in therapies for chronic medical conditions"
http://en.wikipedia.org/wiki/Clinical_trial#Phase_II
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $350.4M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 24.5¢ | 24.0¢ | $196.2K | 810.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 260204 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.5¢ | 132678 | 2 |
View Market Depth
| Last trade - 16.10pm 11/07/2025 (20 minute delay) ? |
| IMM (ASX) Chart |